A project and product profile Surgical wound is a special kind of trauma, recent pain and infection, long-term impact of scar appearance, he gave many of the suffering of patients. Patients with an urgent need for a suture needle can be caused by the elimination of pinholes caused by nerve injury pain, reduce scarring and promote aesthetic medical products. The project is a patented product developed by "negative pressure wound paste", China Patent No.: 200820105229.1. Products used in surgical wound fixed, in the basal layer suture after surgery do not suture the skin with the skin incision will be closed, taking the air on a solid wound closure can not loose, effective in promoting healing, pain can decrease the surgical wound to promote wound healing and reduce scar size. The patented technology has applications for PCT, in most countries around the world have priority, if the investor intends to, I could authorize him or his country to his or his company name. Second, analysis of market demand (for example China) At present, the basic surgical wound closure using the traditional sewing, there is no one-time application of negative pressure wound surgery products, the patented product can be a partial substitute for traditional sewing suture, Medical supplies market has many information for the wound or the negative pressure wound therapy equipment, but they are very expensive, currently used for one-time negative pressure wound surgery medical supplies or blank, the initial market research that: each of the surgical incision in China 600 million, in line with the conditions of use of domestic products 220 million, 10 million worldwide, according to China's 120 and export price 40 U.S. dollars per year to reach a potential market for 260 million yuan, respectively, and 320 million U.S. dollars. In accordance with the development of the domestic market was 20 percent to balance demand is 660,000, the product price 120 yuan, 52,800,000 yuan of corporate profits. 7-year period of patent protection product sales 370 million yuan of profits. 20% of the development of foreign markets, the 51 million U.S. dollars in revenue, 7-year 350 million U.S. dollars revenue.